Guardant Health Inc (GH)
18.60
+0.34
(+1.86%)
USD |
NASDAQ |
May 02, 16:00
18.60
0.00 (0.00%)
After-Hours: 20:00
Guardant Health Research and Development Expense (Quarterly): 89.86M for Dec. 31, 2023
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 89.86M |
| September 30, 2023 | 93.85M |
| June 30, 2023 | 90.36M |
| March 31, 2023 | 93.13M |
| December 31, 2022 | 106.58M |
| September 30, 2022 | 100.02M |
| June 30, 2022 | 85.46M |
| March 31, 2022 | 81.76M |
| December 31, 2021 | 73.02M |
| September 30, 2021 | 70.97M |
| June 30, 2021 | 63.72M |
| March 31, 2021 | 55.51M |
| December 31, 2020 | 40.28M |
| Date | Value |
|---|---|
| September 30, 2020 | 36.24M |
| June 30, 2020 | 36.32M |
| March 31, 2020 | 37.02M |
| December 31, 2019 | 25.88M |
| September 30, 2019 | 24.57M |
| June 30, 2019 | 19.53M |
| March 31, 2019 | 16.32M |
| December 31, 2018 | 16.65M |
| September 30, 2018 | 14.25M |
| June 30, 2018 | 11.55M |
| March 31, 2018 | 8.255M |
| December 31, 2017 | 8.12M |
| September 30, 2017 | 7.246M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
19.53M
Minimum
Jun 2019
106.58M
Maximum
Dec 2022
64.42M
Average
70.97M
Median
Sep 2021
Research and Development Expense (Quarterly) Benchmarks
| Exact Sciences Corp | 114.92M |
| Illumina Inc | 341.00M |
| Delcath Systems Inc | 4.709M |
| CytoSorbents Corp | 4.096M |
| Progyny Inc | -- |